Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans - Wikidata - awgldk - TriplyDB

Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans

Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans

http://www.wikidata.org/entity/Q33781179

about

Follicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft Rejection Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients B cells in chronic graft-versus-host disease The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg Proteasome: target for acute and chronic GVHD?Treatment of chronic graft-versus-host disease with bortezomib Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD Inducible costimulatory molecule deficiency induced imbalance of Treg and Th17/Th2 delays rejection reaction in mice undergoing allogeneic tracheal transplantation Aberrant B-cell homeostasis in chronic GVHD Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.Advances in understanding the pathogenesis of graft-versus-host disease.Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.Circulating T follicular helper cells with increased function during chronic graft-versus-host disease Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.Characterization of T follicular helper cells in allogeneic normal pregnancy and PDL1 blockage-induced abortion.Biology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery.Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.Targeting Cytokines in GVHD Therapy.Preclinical modeling of hematopoietic stem cell transplantation - advantages and limitations.T follicular helper cells in the generation of alloantibody and graft rejection.A Canine Model of Chronic Graft-versus-Host Disease.Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.Notch Signaling and Alloreactivity.Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.Mechanistic approaches for the prevention and treatment of chronic GVHD.A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient population.Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.Regulatory T cell expressed MyD88 is critical for prolongation of allograft survival.Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment.Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner.

P2860

Q26738329-7EC8D720-57C9-42BB-81F5-1F1C6FAA600F Q26787230-827CB04F-90E0-4421-8777-B0D4C10F9A2B Q26861706-AC73E7E6-8382-4ACA-A056-9F549A00783C Q28076264-317A8580-1D24-4A38-A3C7-37D832CD40C7 Q33798102-72E15BCE-26E7-4B75-B1E6-2DF6560FDB39 Q33804224-323FD54B-1457-451B-A50D-6E7A4E9507ED Q34136973-AD417AA7-4922-4D93-9C4D-42C8E424F157 Q34137032-7B144585-C6CC-4C05-8DCE-70102E4F9A30 Q34974093-AE937DEC-CFBE-4A10-90E2-0433B267DD84 Q34978798-87795FDF-0B2F-4EC3-B9CD-49873C09B387 Q35171251-8992D55E-DDE6-4DC4-97A7-76D45E08823C Q35586614-11EAD782-70CF-4216-9C46-BF408AD0C236 Q35738506-17945959-7546-4D1D-92CE-DDFD39E48D9B Q35766798-E4CF68BC-08C9-4A89-84F4-ABA81054226A Q35784522-85BDE005-B20A-4F8B-A6E3-D31C79AE4F2A Q35971439-9B8E4124-1F9B-44C0-AAC5-7F7B41A90802 Q36056986-1E4D4A97-F33B-4510-BA5C-0D762AF6A526 Q36471247-D13C20EF-BD4E-42CF-9A94-F4A9791442E4 Q36851405-F6CAC7F3-DB59-4AA3-84BB-40FE7F6AEECF Q36862931-FBC2557F-3BA6-4878-9B2A-4367F365DAE6 Q36876981-59C8D500-B815-404C-BD5B-A649A964C7CE Q36920466-06457180-42E0-4561-BF46-38DE9583FB1A Q37241480-DB752BF6-D4DF-4EA0-906D-18271E785823 Q37397357-8EE4BA95-E940-42DF-9278-0450DB90C36B Q37522548-78D7E187-AFC7-4E19-A976-AE8DB7C37E25 Q38392246-BE26F3B3-63E1-4B69-A17A-8CC2716D1E10 Q38640486-AE90C2B8-78BB-4266-902F-06CD5C8ADE68 Q38660463-03F7D539-86C1-459E-BF49-FEE9D1A9E53E Q38685919-0D3C8B50-D01C-4D56-A4C4-4BD3817BC6DC Q38778387-BCC32D3B-33ED-4845-9FB4-0846B3C5B761 Q38932342-91737F9B-3EE8-42DD-B658-076B366776D2 Q38949407-E313EEAE-35DA-454A-9AE9-AF887689C412 Q39002164-C06CDE07-47C4-4508-8D9B-A76E4B90714B Q39002166-04DC5D97-25EE-4F01-88B1-5B0F25A90A4A Q39041930-AD310071-F2A8-4094-92EF-BA1ADA012FA7 Q39161011-0DD9D205-289B-4D36-8A96-4B7A91286A09 Q39823591-34D497FA-AEB9-4A02-858D-D91B8ACECACC Q40385568-A7F72EC0-4C03-4911-9AB9-E22B130E3B3F Q41180891-443178FF-1134-4667-B5E3-298A4F949AF9 Q41563521-80D42A37-D6B8-40B5-BBA2-7BD2208AE26F

P2860

Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans

http://www.wikidata.org/entity/Q33781179

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Increased T follicular helper ...... D and bronchiolitis obliterans

@ast

Increased T follicular helper ...... D and bronchiolitis obliterans

@en

type

label

Increased T follicular helper ...... D and bronchiolitis obliterans

@ast

Increased T follicular helper ...... D and bronchiolitis obliterans

@en

prefLabel

Increased T follicular helper ...... D and bronchiolitis obliterans

@ast

Increased T follicular helper ...... D and bronchiolitis obliterans

@en

P1433

Q33781179-4B7F1B4F-4B53-47FC-B965-761D062BA83A

P1476

Q33781179-7E82629D-BB8F-4E0C-BC73-D101F242D620

P2093

Q33781179-0233CD84-BA37-4A1F-908C-41CE27820982

Q33781179-17AED720-3DE2-46F1-87A7-018F8596DE48

Q33781179-1C4ED175-5295-4C6E-B894-D6AFDE9F47EB

Q33781179-35523709-EE8D-4C84-A3C6-0E89D81475B0

Q33781179-3D703CF9-8970-4FA3-AA77-804FDFC02368

Q33781179-505EF945-95CC-489C-80DB-67AF08582FE2

Q33781179-5DFCA742-9D32-4933-89AE-7C59D7B0FBEE

Q33781179-79772E6F-7C23-43E9-A2D1-ED82DDA9156E

Q33781179-86009B0F-0FEC-4C57-A51F-5D1F5662CAAB

Q33781179-88F629FD-33B7-475D-AB35-5ED6EB68B704

P2860

Q33781179-01E89D12-B30B-47E0-AF12-E7531D51C076

Q33781179-01ECC415-9F86-4DB9-8B6A-517EBD41B5D7

Q33781179-07F67C15-B81A-4A79-B366-D583DDD61CFD

Q33781179-0983B7C9-7EFD-4C0F-B82A-E880757A8847

Q33781179-0ABB4397-8B9D-4AC2-9665-C3A4762D6634

Q33781179-0E880BD2-D24D-4E45-85D1-8783662A13F8

Q33781179-0F1B357A-8075-4E15-B3AE-23B45DB5A338

Q33781179-0F5A6736-C030-451D-AB98-5D5AB14DB9D3

Q33781179-0F7F1ECA-35B1-471D-8279-373682045836

Q33781179-2FD47E7C-E3B5-4C7D-908D-4EA2EA496672

P304

Q33781179-41F50BD5-276D-4EC6-9E77-D392B0F5C63A

P31

Q33781179-A0C8B64F-8412-4AB6-8496-ACAF8A6C9CD1

P356

Q33781179-AE8845B4-FA68-40D6-A012-0DEC58F211BB

P407

Q33781179-A162CFDD-E2EB-45DE-901F-180ADBFE0A8B

P433

Q33781179-4EDD4139-B849-4E85-8039-DEB18BBC90F6

P478

Q33781179-402343D6-9734-4370-938F-388BD4F95F0F

P50

Q33781179-031D40AC-1385-476E-A423-6673D213768F

Q33781179-14421D4D-E6F9-425F-85DC-A3C4FAF909AF

Q33781179-44AA6C4C-3289-4AF8-8EF3-28EBF00051E7

Q33781179-708A97E6-6C46-443B-8CB2-AAA8DEFB481D

Q33781179-7AC8E515-0E82-459D-BF06-F6CA31D44AB7

Q33781179-862CAB70-FBD6-42D7-86EC-64106700050F

Q33781179-8FD0EC00-4D86-4538-A031-326C0CF39F5D

Q33781179-F74AC6BA-6EDC-41DB-B56B-BE421A2952DD

P577

Q33781179-914A785A-275F-4C9F-A350-18B79974886B

P5875

Q33781179-01342C48-9ADE-4016-8177-4164B8943F63

P698

Q33781179-F3B42CAD-2E81-40D4-8C89-BC86D65B917A

P921

Q33781179-9F94A8AF-8D6A-4540-A96C-A05D39282128

P932

Q33781179-8C765E78-95EE-475F-96AE-3C3FB41BC894

P356

BLOOD-2014-03-562231

P1433

P1476

Increased T follicular helper ...... D and bronchiolitis obliterans

@en

P2093

Corey Cutler

http://www.w3.org/2001/XMLSchema#string

David H Munn

http://www.w3.org/2001/XMLSchema#string

Dawn K Reichenbach

http://www.w3.org/2001/XMLSchema#string

Gordon J Freeman

http://www.w3.org/2001/XMLSchema#string

Ivan Maillard

http://www.w3.org/2001/XMLSchema#string

Jason A Dubovsky

http://www.w3.org/2001/XMLSchema#string

Jing Du

http://www.w3.org/2001/XMLSchema#string

John Koreth

http://www.w3.org/2001/XMLSchema#string

Joseph H Antin

http://www.w3.org/2001/XMLSchema#string

Leo Luznik

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

A critical role for IL-21 in regulating immunoglobulin production

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.

IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism.

IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses.

Cytokine blockade in rheumatoid arthritis.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

The IL-21 receptor augments Th2 effector function and alternative macrophage activation

Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone.

Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans

P304

3988-3998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-03-562231

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan S. Serody

Geoffrey R Hill

Kelli P MacDonald

Angela Panoskaltsis-Mortari

Stefanie Sarantopoulos

P577

2014-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262265213

http://www.w3.org/2001/XMLSchema#string

P698

24820310

http://www.w3.org/2001/XMLSchema#string

P921

P932

4064335

http://www.w3.org/2001/XMLSchema#string